scholarly journals Studies on the Mechanism of Gegen Qinlian Decoction in Treating Diabetes Mellitus Based on Network Pharmacology

2021 ◽  
Vol 16 (1) ◽  
pp. 1934578X2098213
Author(s):  
Xiaodong Deng ◽  
Yuhua Liang ◽  
Jianmei Hu ◽  
Yuhui Yang

Diabetes mellitus (DM) is a chronic disease that is very common and seriously threatens patient health. Gegen Qinlian decoction (GQD) has long been applied clinically, but its mechanism in pharmacology has not been extensively and systematically studied. A GQD protein interaction network and diabetes protein interaction network were constructed based on the methods of system biology. Functional module analysis, Kyoto Encyclopedia of Genes and Genomes pathway analysis, and Gene Ontology (GO) enrichment analysis were carried out on the 2 networks. The hub nodes were filtered by comparative analysis. The topological parameters, interactions, and biological functions of the 2 networks were analyzed in multiple ways. By applying GEO-based external datasets to verify the results of our analysis that the Gene Set Enrichment Analysis (GSEA) displayed metabolic pathways in which hub genes played roles in regulating different expression states. Molecular docking is used to verify the effective components that can be combined with hub nodes. By comparing the 2 networks, 24 hub targets were filtered. There were 7 complex relationships between the networks. The results showed 4 topological parameters of the 24 selected hub targets that were much higher than the median values, suggesting that these hub targets show specific involvement in the network. The hub genes were verified in the GEO database, and these genes were closely related to the biological processes involved in glucose metabolism. Molecular docking results showed that 5,7,2', 6'-tetrahydroxyflavone, magnograndiolide, gancaonin I, isoglycyrol, gancaonin A, worenine, and glyzaglabrin produced the strongest binding effect with 10 hub nodes. This compound–target mode of interaction may be the main mechanism of action of GQD. This study reflected the synergistic characteristics of multiple targets and multiple pathways of traditional Chinese medicine and discussed the mechanism of GQD in the treatment of DM at the molecular pharmacological level.

2021 ◽  
Vol 2021 ◽  
pp. 1-10
Author(s):  
Minglong Guan ◽  
Lan Guo ◽  
Hengli Ma ◽  
Huimei Wu ◽  
Xiaoyun Fan

Rosmarinic acid (RosA) is a natural phenolic acid compound, which is mainly extracted from Labiatae and Arnebia. At present, there is no systematic analysis of its mechanism. Therefore, we used the method of network pharmacology to analyze the mechanism of RosA. In our study, PubChem database was used to search for the chemical formula and the Chemical Abstracts Service (CAS) number of RosA. Then, the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) was used to evaluate the pharmacodynamics of RosA, and the Comparative Toxicogenomics Database (CTD) was used to identify the potential target genes of RosA. In addition, the Gene Ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of target genes were carried out by using the web-based gene set analysis toolkit (WebGestalt). At the same time, we uploaded the targets to the STRING database to obtain the protein interaction network. Then, we carried out a molecular docking about targets and RosA. Finally, we used Cytoscape to establish a visual protein-protein interaction network and drug-target-pathway network and analyze these networks. Our data showed that RosA has good biological activity and drug utilization. There are 55 target genes that have been identified. Then, the bioinformatics analysis and network analysis found that these target genes are closely related to inflammatory response, tumor occurrence and development, and other biological processes. These results demonstrated that RosA can act on a variety of proteins and pathways to form a systematic pharmacological network, which has good value in drug development and utilization.


2020 ◽  
Vol 17 (6) ◽  
pp. 566-575 ◽  
Author(s):  
Yukun Zhu ◽  
Xuelu Ding ◽  
Zhaoyuan She ◽  
Xue Bai ◽  
Ziyang Nie ◽  
...  

Background: Alzheimer’s Disease (AD) and Type 2 Diabetes Mellitus (T2DM) have an increased incidence in modern society. Although increasing evidence has supported the close linkage between these two disorders, the inter-relational mechanisms remain to be fully elucidated. Objective: The primary purpose of this study is to explore the shared pathophysiological mechanisms of AD and T2DM. Methods: We downloaded the microarray data of AD and T2DM from the Gene Expression Omnibus (GEO) database and constructed co-expression networks by Weighted Gene Co-Expression Network Analysis (WGCNA) to identify gene network modules related to AD and T2DM. Then, Gene Ontology (GO) and pathway enrichment analysis were performed on the common genes existing in the AD and T2DM related modules by clusterProfiler and DOSE package. Finally, we utilized the STRING database to construct the protein-protein interaction network and found out the hub genes in the network. Results: Our findings indicated that seven and four modules were the most significant with AD and T2DM, respectively. Functional enrichment analysis showed that AD and T2DM common genes were mainly enriched in signaling pathways such as circadian entrainment, phagosome, glutathione metabolism and synaptic vesicle cycle. Protein-protein interaction network construction identified 10 hub genes (CALM1, LRRK2, RBX1, SLC6A1, TXN, SNRPF, GJA1, VWF, LPL, AGT) in AD and T2DM shared genes. Conclusions: Our work identified common pathogenesis of AD and T2DM. These shared pathways might provide a novel idea for further mechanistic studies and hub genes that may serve as novel therapeutic targets for diagnosis and treatment of AD and T2DM.


2020 ◽  
Author(s):  
Li-ying Jia ◽  
Jia Li ◽  
Gui-yun Cao ◽  
Zhao-qing Meng ◽  
Lu Gan ◽  
...  

Abstract Background SheXiang XinTongNing, a commercially available Chinese patent medicine, has been widely used in the treatment of coronary heart disease. However, the mechanisms of SheXiang XinTongNing are still unclear. The aim of this study was to investigate the pharmacological mechanisms of SheXiang XinTongNing against coronary heart disease via network analysis. Method The traditional Chinese medicine system pharmacology analysis platform was used to screen the potential active constituents of the six traditional Chinese medicines in SheXiang XinTongNing, and the potential targets were obtained from PharmMapper. The genome annotation database platform was used to screen the candidate targets related to coronary heart disease. Then the drug-components-targets network and protein interaction network were built by Cytoscape 3.6.0 software. Further, GO bio-functional enrichment analysis and KEGG pathway enrichment analysis were performed through annotation, visualization and integrated discovery database. Results Results showed that the drugs-components-targets network contains 104 targets and 62 key components. The protein interaction network consisted of 107 nodes; key targets included Bcl2l1, IGF1, SRC, CASP3, et al. Functionally, the candidate targets were significantly associated with multiple pathways such as PI3K-Akt signaling pathway, MAPK signaling pathway, Ras signaling pathway, FoxO signaling pathway, Endocrine resistance. Given the above, the pharmacological activities of SheXiang XinTongNing may be predominantly related to several factors such as cell apoptosis, inflammation and angiogenesis. Conclusion XTN can effectively attenuate the symptoms of coronary heart disease through diverse pathways. The research proves that network pharmacology can successfully reveal the mechanisms of traditional Chinese medicine in a holistic view. Our systematic analysis lays a foundation for further studying.


2020 ◽  
Vol 2020 ◽  
pp. 1-13
Author(s):  
Zhengquan Huang ◽  
Xiaoqing Shi ◽  
Xiaochen Li ◽  
Li Zhang ◽  
Peng Wu ◽  
...  

Objective. To explore the molecular mechanism of Simiao powder in the treatment of knee osteoarthritis. Methods. Based on oral bioavailability and drug-likeness, the main active components of Simiao powder were screened using the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP). GeneCard, OMIM, DisGeNET, DrugBank, PharmGkb, and the Therapeutic Target Database were used to establish target databases for knee osteoarthritis. Cytoscape software was used to construct a visual interactive network diagram of “active ingredient - action target – disease.” The STRING database was used to construct a protein interaction network and analyze related protein interaction relationships. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway and Gene Ontology (GO) biological process enrichment analysis were performed on the core targets. Additionally, Discovery Studio software was used for molecular docking verification of active pharmaceutical ingredients and disease targets. Results. Thirty-seven active components of Simiao powder were screened, including 106 common targets. The results of network analysis showed that the targets were mainly involved in regulating biological processes such as cell metabolism and apoptosis. Simiao powder components were predicted to exert their therapeutic effect on the AGE-RAGE signaling pathway in diabetic complications, IL-17 signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, and HIF-1 signaling pathway. The molecular docking results showed that the active components of Simiao powder had a good match with the targets of IL1B, MMP9, CXCL8, MAPK8, JUN, IL6, MAPK1, EGF, VEGFA, AKT1, and PTGS2. Conclusion. Simiao powder has multisystem, multicomponent, and multitarget characteristics in treating knee osteoarthritis. Its possible mechanism of action includes inhibiting the inflammatory response, regulating immune function, and resisting oxidative stress to control the occurrence and development of the disease. Quercetin, wogonin, kaempferol, beta-sitosterol, and other active ingredients may be the material basis for the treatment of knee osteoarthritis.


2021 ◽  
Author(s):  
Zhu Lili ◽  
Zhu YuKun ◽  
Zhuangzhuang Tian ◽  
Yongsheng Li ◽  
Liyu Cao

Abstract Background Classic Hodgkin lymphoma (CHL) is the most common HL in the modern society. Although the treatment of cHL has made great progress, its molecular mechanisms have yet to be deciphered. Objectives The purpose of this study is to find out the crucial potential genes and pathways associated with cHL. Methods We downloaded the cHL microarray dataset (GSE12453) from Gene Expression Omnibus (GEO) database and to identify the differentially expressed genes (DEGs) between cHL samples and normal samples through the limma package in R. Then, gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of DEGs were carried out. Finally, we constructed the protein-protein interaction network to screen out the hub genes using Search Tool for the Retrieval of Interacting Genes (STRING) database. Results We screened out 788 DEGs in the cHL dataset, such as BATF3, IER3, RAB13 and FCRL2. GO functional enrichment analysis indicated that the DEGs were related with regulation of lymphocyte activation, secretory granule lumen and chemokine activity. KEGG pathway analysis showed that the genes enriched in Prion disease, Complement and coagulation cascades and Parkinson disease Coronavirus disease-COVID-19 pathway. Protein-protein interaction network construction identified 10 hub genes (IL6, ITGAM, CD86, FN1, MMP9, CXCL10, CCL5, CD19, IFNG, SELL, UBB) in the network. Conclusions In the present investigation, we identified several pathways and hub genes related to the occurrence and development of cHL, which may provide an important basis for further research and novel therapeutic targets and prognostic indicators for cHL.


Author(s):  
Xianhai Li ◽  
Hua Tang ◽  
Qiang Tang ◽  
Wei Chen

Huang-Lian-Jie-Du decoction (HLJDD) has been used to treat pneumonia for thousands of years in China. However, our understanding of its mechanisms on treating pneumonia is still unclear. In the present work, network pharmacology was used to analyze the potential active ingredients and molecular mechanisms of HLJDD on treating pneumonia. A total of 102 active ingredients were identified from HLJDD, among which 54 were hit by the 69 targets associated with pneumonia. By performing Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis, we obtained the main pathways associated with pneumonia and those associated with the mechanism of HLJDD in the treatment of pneumonia. By constructing the protein–protein interaction network of common targets, 10 hub genes were identified, which were mainly involved in the tumor necrosis factor (TNF) signaling pathway, interleukin 17 (IL-17) signaling pathway, and nucleotide-binding oligomerization domain (NOD)-like receptor signaling pathway. Moreover, the results of molecular docking showed that the active ingredients of HLJDD had a good affinity with the hub genes. The final results indicate that HLJDD has a greater effect on bacterial pneumonia than on viral pneumonia. The therapeutic effect is mainly achieved by regulating the host immune inflammatory response and oxidative stress reaction, antibacterial microorganisms, alleviating the clinical symptoms of pneumonia, repairing damaged cells, and inhibiting cell migration.


2020 ◽  
Author(s):  
Lin Xu ◽  
Jiaqi Zhang ◽  
Zedan Zhang ◽  
Yifan Wang ◽  
Fengyun Wang ◽  
...  

Abstract Background and objective: Ge-Gen-Qin-Lian Decoction (GGQLD), a traditional Chinese medicine (TCM) formula, has been widely used for ulcerative colitis (UC) in China while the pharmacological mechanisms still remain unclear. The present research was designed to clarify the underlying mechanism of GGQD against UC. Methods: In this research, a GGQLD-compound-target-UC (G-U) network was constructed based on public databases to clarify the relationship between active compounds in GGQLD and potential targets. GO and KEGG pathway enrichment analyses were performed to investigate biological functions associated with potential targets. A protein-protein interaction network was constructed to screen and evaluate hub genes and key active ingredients, another GO and KEGG pathway analyses were subsequently performed on hub genes. Molecular docking was used to verify the activities of binding between hub targets and ingredients. Results: Finally, 83 potential therapeutic targets and 118 correspond active ingredients were obtained by network pharmacology. GO and KEGG enrichment analysis revealed that GGQLD had an effect of anti-inflammation, antioxidation, and immunomodulatory. The effect of GGQLD on UC might be achieved by regulating the balance of cytokines (eg., IL6, TNF, IL1β, CXCL8, CCL2, IL10, IL4, IL2) in immune system and inflammation-related pathways, such as IL-17 pathway and Th17 cell differentiation pathway. Besides, molecular docking results demonstrated that the main active ingredients, quercetin, exhibited good affinity to hub targets. Conclusion: This research fully reflects the characteristics of multi-component and multi-target for GGQLD in the treatment of UC. Furthermore, the present study provided new insight into the mechanisms of GGQLD against UC.


2020 ◽  
Author(s):  
Mehrdad Ameri ◽  
Haniye Salimi ◽  
Sedigheh Eskandari ◽  
Navid Nezafat

Abstract Background: Hepatocellular carcinoma (HCC) is one of the leading causes of death worldwide. Identification of potential therapeutic and diagnostic biomarkers can be helpful to screen cancer progress. This study implemented with the aim of discovering potential biomarkers for HCC within a network-based approach integrated with microarray data. Methods: Through downloading a gene expression profile GSE62232 differentially expressed genes (DEGs) were identified. Gene ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis for DEGs were performed utilizing enrichr server. Following reconstruction of protein-protein interaction network of DEGs with STRING, network visualization, analyses, and clustering into structural modules carried out using Cytoscape. Considering degree centrality, 15 hub genes were selected as early biomarker candidates for final validation. In order to validate hub genes, GEPIA server was used to perform overall survival (OS) and disease-free survival (DFS). Results: In our approach 1996 DEGs were identified including 995 up-regulated genes and 1001 down-regulated genes. KEGG pathway enrichment analysis shown that DEGs are associated with Chemical carcinogenesis, and Cell cycle. GO term enrichment analysis indicated the relation of DEGs with epoxygenase P450 pathway, arachidonic acid monooxygenase activity, and secretory granule lumen. Following analysis of protein-protein interaction network of DEGs top three structural modules and 15 early hub genes were selected. Validation of hub genes performed using GEPIA. Consequently, CDK1, CCNB1, CCNA2, CDC20, AURKA, MAD2L1, TOP2A, KIF11, BUB1B, TYMS, EZH2, and BUB1 were considered as our final proposed biomarkers. Conclusion: using an integrated network-based approach with microarray data our results revealed 12 final candidates with potential to considered as biomarkers in hepatocellular carcinoma.


Sign in / Sign up

Export Citation Format

Share Document